|Articles|October 19, 2015
Rudolph Navari on Preventing CINV With Olanzapine
Author(s)Rudolph Navari
Rudolph Navari, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.
Advertisement
Rudolph Navari, director, Cancer Care Program in Central and South America, World Health Organization, professor of medicine, Indiana University School of Medicine-South Bend, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
A Gift from the Sea
2
Top 3 Takeaways From WCLC 2026 That Patients Should Know
3
New Myeloma Combo Cuts Risk of Relapse by Up to 72% — Here's What It Could Mean for You
4
After His Daughter’s Cancer Treatment, AJ Wyman Realized He Needed Help, Too
5